On Thursday, September 17, Anthony Morel discussed a groundbreaking retinal implant during the Good Morning Business program on Culture IA. This implant is designed to restore vision to individuals who are blind and has recently received approval for commercial use in Europe. The technology represents a significant advancement in medical science, offering hope to those who have lost their sight due to conditions such as retinitis pigmentosa or age-related macular degeneration. The retinal implant works by bypassing damaged parts of the eye and directly stimulating the visual cortex of the brain. This is achieved through a small device implanted in the retina, which converts visual information into electrical signals. These signals are then transmitted to the brain, allowing the individual to perceive light and shapes, even if they have no natural vision. While the implant does not restore full vision, it can significantly improve the quality of life for blind individuals by enabling them to navigate their surroundings more independently. The approval of this implant in Europe marks a key milestone in its development. It means that the device can now be made available to patients through healthcare systems and private providers across the continent. This follows years of clinical trials and research aimed at ensuring the safety and effectiveness of the technology. The implant is considered a major step forward in the field of neuroprosthetics, which involves the use of technology to replace or enhance lost sensory or motor functions. The Good Morning Business program, which airs from Monday to Friday, is a popular source of business and economic news. Listeners can access the program as a podcast, allowing them to stay informed about developments in various industries, including healthcare and medical technology. Morel’s discussion on the retinal implant highlights the program’s focus on covering innovative advancements that have real-world applications and implications for society.